These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11180747)

  • 1. Duchenne Muscular Dystrophy.
    Iannaccone ST; Nanjiani Z
    Curr Treat Options Neurol; 2001 Mar; 3(2):105-117. PubMed ID: 11180747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update of steroid therapy for Duchenne muscular dystrophy].
    Takeuchi F; Komaki H
    No To Hattatsu; 2015 Jul; 47(4):266-71. PubMed ID: 26353447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis in Duchenne Muscular Dystrophy After Changing Steroids.
    Abutaleb ARA; McNally EM; Khan SS; Anderson AS; Carr JC; Wilcox JE
    JAMA Cardiol; 2018 Oct; 3(10):1006-1010. PubMed ID: 30167630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD).
    Crabtree NJ; Roper H; Shaw NJ
    Bone; 2022 Jan; 154():116248. PubMed ID: 34718220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice with steroid therapy for Duchenne muscular dystrophy: An expert survey in Asia and Oceania.
    Takeuchi F; Nakamura H; Yonemoto N; Komaki H; Rosales RL; Kornberg AJ; Bretag AH; Dejthevaporn C; Goh KJ; Jong YJ; Kim DS; Khadilkar SV; Shen D; Wong KT; Chai J; Chan SH; Khan S; Ohnmar O; Nishino I; Takeda S; Nonaka I
    Brain Dev; 2020 Mar; 42(3):277-288. PubMed ID: 31980267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy].
    Bernert G; Hahn A; Köhler C; Meyer S; Schara U; Schlachter K; Trollmann R; Walter MC
    Nervenarzt; 2021 Apr; 92(4):359-366. PubMed ID: 33215271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy.
    Lamb MM; Cai B; Royer J; Pandya S; Soim A; Valdez R; DiGuiseppi C; James K; Whitehead N; Peay H; Venkatesh SY; Matthews D;
    Am J Med Genet A; 2018 Nov; 176(11):2350-2358. PubMed ID: 30256515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
    West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
    J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.
    Passamano L; Taglia A; Palladino A; Viggiano E; D'Ambrosio P; Scutifero M; Rosaria Cecio M; Torre V; DE Luca F; Picillo E; Paciello O; Piluso G; Nigro G; Politano L
    Acta Myol; 2012 Oct; 31(2):121-5. PubMed ID: 23097603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications.
    Galetaki D; Szymczuk V; Shi M; Merchant N
    eNeurologicalSci; 2024 Sep; 36():100513. PubMed ID: 38989274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
    Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of steroids and ischial weight-bearing knee ankle foot orthoses in Duchenne's muscular dystrophy prolongs ambulation past 20 years of age--a case report.
    Pardo AC; Do T; Ryder T; Meyer A; Miles L; Wong BL
    Neuromuscul Disord; 2011 Nov; 21(11):800-2. PubMed ID: 21784636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.
    LoMauro A; D'Angelo MG; Aliverti A
    Ther Clin Risk Manag; 2015; 11():1475-88. PubMed ID: 26451113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients.
    Takeuchi F; Yonemoto N; Nakamura H; Shimizu R; Komaki H; Mori-Yoshimura M; Hayashi YK; Nishino I; Kawai M; Kimura E; Takeda S
    J Neurol; 2013 Dec; 260(12):3023-9. PubMed ID: 24057148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy.
    Schram G; Fournier A; Leduc H; Dahdah N; Therien J; Vanasse M; Khairy P
    J Am Coll Cardiol; 2013 Mar; 61(9):948-54. PubMed ID: 23352781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
    Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
    Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.